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Abstract
Objectives To determine the incidence of unintended
pregnancy among female sex workers (FSWs) in lowincome and middle-income countries (LMICs).
Design We searched MEDLINE, PsychInfo, Embase and
Popline for papers published in English between January
2000 and January 2016, and Web of Science and Proquest
for conference abstracts. Meta-analysis was performed on
the primary outcomes using random effects models, with
subgroup analysis used to explore heterogeneity.
Participants Eligible studies targeted FSWs aged 15–49
years living or working in an LMIC.
Outcome measures Studies were eligible if they
provided data on one of two primary outcomes: incidence
of unintended pregnancy and incidence of pregnancy
where intention is undefined. Secondary outcomes were
also extracted when they were reported in included
studies: incidence of induced abortion; incidence of birth;
and correlates/predictors of pregnancy or unintended
pregnancy.
Results Twenty-five eligible studies were identified
from 3866 articles. Methodological quality was low
overall. Unintended pregnancy incidence showed high
heterogeneity (I²>95%), ranging from 7.2 to 59.6 per 100
person-years across 10 studies. Study design and duration
were found to account for heterogeneity. On subgroup
analysis, the three cohort studies in which no intervention
was introduced had a pooled incidence of 27.1 per 100
person-years (95% CI 24.4 to 29.8; I2=0%). Incidence
of pregnancy (intention undefined) was also highly
heterogeneous, ranging from 2.0 to 23.4 per 100 personyears (15 studies).
Conclusions Of the many studies examining FSWs’
sexual and reproductive health in LMICs, very few
measured pregnancy and fewer assessed pregnancy
intention. Incidence varied widely, likely due to differences
in study design, duration and baseline population risk,
but was high in most studies, representing a considerable
concern for this key population. Evidence-based
approaches that place greater importance on unintended
pregnancy prevention need to be incorporated into
existing sexual and reproductive health programmes for
FSWs.
PROSPERO registration number CRD42016029185

Strengths and limitations of this study
►► This is the first study to systematically review and

analyse the incidence of pregnancy or unintended
pregnancy among female sex workers (FSWs) in
low-income and middle-income countries.
►► Broad inclusion criteria meant that the review allowed for the inclusion of a large proportion of the
studies that have collected data on pregnancy or
unintended pregnancy rates in this population.
►► However, limitations of broad inclusion criteria are
that only one study had an a priori objective of measuring pregnancy incidence, and studies were highly
varied in terms of their methodology, settings and
study populations.
►► High heterogeneity prevented pooled analysis of all
studies but allowed for subgroup analysis for cohort
studies and for studies in which no intervention was
introduced.
►► Pregnancy rates among FSWs could not be compared with the background general population rates
because of the lack of availability of those data.

Introduction
Unintended pregnancy affects a large number
of women in low-income and middle-income
countries (LMICs) and can have significant
impacts on maternal and child health.1–3
Unintended pregnancy is a high priority
issue for many female sex workers (FSWs)4 5
who usually have dependents to support and
for whom pregnancy may increase financial
dependence on sex work and add to already
high levels of stigmatisation.5 This has been
confirmed by consultation with FSWs in
Kenyai and workshops with FSWs to inform
development of a pregnancy prevention intervention.6 Participants expressed considerable
i

Our research group has worked closely with a local
NGO (International Centre for Reproductive Health,
Kenya) which has a long history of collaborating with and
providing services for sex workers in Mombasa.
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fear and anxiety about pregnancy, related personal and
peer experiences of pregnancy scares and emphasised
the importance of improving knowledge of family planning in their community (unpublished qualitative data,
Mombasa, Kenya).
FSWs can face elevated risks of unintended pregnancy
due to a high frequency of intercourse and a high number
of sexual partners.7 8 Risks are exacerbated by concurrent paying and non-paying partnerships8 and by sexual
and gender-based violence, gender inequalities and
stigma towards sex work, which reduce women’s power
to negotiate within sexual relationships.9–11 While gains
have been made in terms of condom use with paying
clients,12 rates of condom and other contraceptive use
are consistently lower with emotional (non-paying) partners.5 13 14 In many countries, particularly in sub-Saharan
Africa, few FSWs use long-acting reversible contraceptives
(intrauterine devices and implants), and methods such as
injections, condoms and pills may be used inconsistently
or incorrectly, rendering them less effective.5 15 Limited
knowledge and misunderstandings, particularly in relation to contraceptive side effects and impacts on fertility,
are significant demand-side barriers to contraceptive
uptake.4 5 16
Family planning services are often neglected as part of
FSW-specific service provision, which have focused largely
on preventing HIV and other sexually transmitted infections (STIs).12 17–19 Stigma of health workers towards sex
workers can also limit access to contraception.20 21 FSWs
have the same reproductive rights as all women, and their
desires and needs in relation to pregnancy have often
been neglected,22–24 similar to other marginalised populations, which have historically been subjected to reproductive coercion.25 26 It is important that those who do
desire pregnancy are provided with non-judgemental
care and that those who do not are given the opportunity and resources to prevent it. Moreover, many FSWs
who become pregnant may be reluctant to enter maternal
health services, given their previous experiences of
discrimination and abuse from health workers.20 FSW
programmes need to make concerted efforts to facilitate
timely attendance of FSW at antenatal clinic and childbirth services. Importantly, FSWs often have remarkably
high levels of HIV, and maternal health services are a key
entry point for them to access antiretroviral treatment,
which secures their health and reduces HIV in infants.
Despite a clear rationale for addressing unintended
pregnancy in this population, it is important to acknowledge that intention is a problematic concept, which
is more accurately represented as a spectrum than a
dichotomy.3 27 Indeed, many women feel positive about
pregnancy despite not intending to conceive, or may
simultaneously desire both pregnancy and its avoidance,
for different reasons. The degree to which women accept
or welcome a pregnancy once it has occurred has been
hypothesised to be a more important predictor of adverse
outcomes than prepregnancy intentions.27 Fertility preferences are also likely to be less stable over time in LMICs
2

undergoing fertility transition compared with high-income countries.3 FSWs’ intentions also differ between
types of partner, requiring them to adapt contraceptive
use accordingly.22 Furthermore, as a stigmatised group,
FSWs may feel pressure not to disclose their intention.
Despite these limitations, we have continued to use the
term ‘unintended pregnancy’ in this paper for the sake of
consistency with other literature and the lack of a feasible
alternative.
The primary objective of this study was to determine
the pooled incidence of unintended pregnancy among
FSWs in LMICs. Given the expected low number of
eligible studies, we also aimed to determine the incidence
of pregnancy where intention is not known. Secondary
aims were to examine the correlates and predictors of
pregnancy and the incidence of induced abortion and
childbirth in this population.

Methods
All stages of this systematic review and meta-analysis have
been reported in line with the Preferred Reporting Items
for Systematic Reviews and Meta-Analyses statement.28
The protocol for this review was registered with the international prospective register of systematic reviews (PROSPERO): number CRD42016029185.
Inclusion and exclusion criteria
Studies were included if they met key criteria in terms
of population, outcomes and study design. FSWs had to
account for at least two-thirds of the sample, unless data
could be disaggregated by sex work status. We employed
a broad definition of sex work, including women who
self-identified as sex workers, those who engaged in
transactional sex or part-time sex work and communities of women known to practice commercial or transactional sex. Study participants had to live or work in an
LMIC29 and be of reproductive age (15–49 years). Studies
targeting women with reduced fertility (eg, women in
the first 6 months postpartum and those exclusively
breast feeding or undergoing fertility treatment) were
excluded.
Studies had to measure or report one of the following
primary outcomes:
1. Cumulative incidence (proportion of women who became pregnant in a defined time period) or incidence
rate (per person-time) of unintended pregnancy.
2. Cumulative incidence or incidence rate of pregnancy
(where intention is not measured).
Unintended pregnancy was defined as any pregnancy
considered by the woman to be not planned, intended
or desired at the time of conception,30 as reported either
prior to pregnancy or retrospectively. Such pregnancies may be described by the authors as unintended,
unwanted, undesired, unplanned or mistimed.
Any study design that was able to measure one or more of
the primary outcomes was considered, including both observational and intervention studies. Case studies, ecological
Ampt FH, et al. BMJ Open 2018;8:e021779. doi:10.1136/bmjopen-2018-021779
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studies, qualitative studies, editorials and commentaries
were excluded. We planned to expand the inclusion criteria
if insufficient studies measuring the primary outcomes were
identified to include studies reporting prevalence of pregnancy in the previous 12 months. Cross-sectional studies
were included in the initial screen for this purpose but were
subsequently excluded as there were sufficient longitudinal
studies measuring incidence. The addition of period prevalence in the last 12 months as an outcome would have
required additional subanalyses; in addition, measurement
of retrospective pregnancy intention in cross-sectional
studies differs from prospective measurement as women
may change their minds during the course of their pregnancy. Only studies published in English since 1 January
2000 were included.
Search strategy
A systematic electronic search of MEDLINE, Embase,
PsychINFO and Popline was undertaken to identify relevant peer-reviewed articles. Search syntax included, as both
subject headings and keywords: synonyms for ‘sex work’;
list of LMICs from the World Bank29 and synonyms for
‘low- and middle-income’; and study design and descriptor
terms, for example, ‘cohort studies’ or ‘controlled trials’
(full search strategy in online supplementary file).
A search for unpublished grey literature was also undertaken, including conference proceedings and abstracts (via
Web of Science and Proquest databases), research theses
and the websites of relevant non-government organisations, including the Population Council, FHI 360 and Guttmacher Institute.
The last search was performed on 20 January 2016. Up
to two attempts were made to contact authors when further
information was required. Eligible studies recommended
by contacted authors were also included.
Screening and data extraction
Screening of all abstracts, removal of duplicates and selection of full-text articles was conducted by one researcher,
with a random selection of 10% screened in duplicate. Data
from a random sample of 50% of included full-text manuscripts were extracted in duplicate. Discrepancies in eligibility and data extraction were resolved by discussion, with
a third researcher arbitrating when necessary.
Summary estimates were sought rather than individual
subject data. Data were extracted relating to: eligibility
criteria; study aims, population and methods; setting
and participant characteristics at baseline; primary and
secondary outcome data for each time point reported;
and quality assessment criteria. In addition to the primary
outcomes, the following secondary outcomes were
extracted: incidence of induced abortion (termination
of pregnancy); incidence of birth; and correlates/predictors of pregnancy or unintended pregnancy. Authors were
contacted to provide data relating to the primary outcome
when it was not reported in the paper, for example, the
total person-years of exposure.
Ampt FH, et al. BMJ Open 2018;8:e021779. doi:10.1136/bmjopen-2018-021779

Quality assessment
Methodological quality of the included studies was assessed
using a modified version of the Joanna Briggs Institute
Prevalence Critical Appraisal Tool31 (online supplementary
file). This tool was designed to assess studies measuring
prevalence or incidence and can be applied to multiple
study designs. The tool was modified to address specific
methodological concerns of our research question. Given
measurement bias could result from infrequent or irregular pregnancy detection methods, items on these methods
were specifically included. We also documented whether
pregnancy incidence was an a priori study objective.
Quality assessment was undertaken in duplicate for 50%
of studies, with discrepancies resolved by discussion. Studies
were given a score out of 15 if they measured unintended
pregnancy incidence, and a score out of 14 if they measured
pregnancy incidence (the latter did not include an item on
measurement of intention). Scores were then reported as
percentages.
Analysis
We undertook a qualitative narrative synthesis of both
primary and secondary outcomes and quantitative analysis of primary outcomes using Stata V.13.1.
Incidence rate (per 100 person-years) was taken as
the unit of analysis. In studies reporting only cumulative
incidence, we estimated person-time, censoring women
at their first pregnancy and assuming that they became
pregnant halfway through the study.
The Mantel-Haenszel I2 statistic was over 95% for
both primary outcomes, so meta-analysis and meta-regression were not performed for all eligible studies, as
had been planned. Instead, sources of heterogeneity
were explored using subgroup analyses, and pooled
incidence rates were calculated using DerSimonian &
Laird random effects models for subgroups containing
more than two studies and with I2 of less than 75%. The
explored subgroups were clustered as covariates that may
explain heterogeneity (geographic region and intervention vs non-intervention) and potential methodological
explanations of heterogeneity: study design (cohort vs
randomised controlled trial (RCT); study duration; and
frequency of pregnancy measurement (measured regularly vs only when indicated). Interventions included
any introduced by the study with the aim of improving
sexual and reproductive health, including contraceptive
provision and behavioural or biomedical interventions to
prevent HIV/STIs.
We assessed study quality as a source of heterogeneity
by examining scatter plots and Pearson correlation coefficients of quality score against incidence rate. We also
qualitatively explored characteristics of different studies,
including the following baseline population characteristics that may have impacted on pregnancy rates:
age; contraceptive prevalence; consistent condom use;
number of sex partners; coital frequency; STI prevalence;
indicators of gender-based violence; and alcohol and
other drug use.
3
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Figure 1 PRISMA flow diagram of search results and inclusion of studies after review.28 FSWs, female sex workers; LMICs,
low-income and middle-income countries; PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses.

Patient and public involvement
The research question and outcome measures were
informed by previous qualitative work with FSWs
conducted by the International Centre for Reproductive
Health, Kenya. This confirmed that unintended pregnancy was an important issue for this population group.
Patients and members of the public were not otherwise
involved in the design or conduct of this study.
Results
The initial search yielded 6523 peer-reviewed and 118 grey
literature articles and 11 identified by hand-searching
(eg, due to recommendations from contacted authors).
After removal of duplicates, this resulted in 3866 articles
(figure 1). Based on title and abstracts, 750 manuscripts
remained for full-text screening.
Pregnancy incidence was reported in 12 studies and was
obtained for a further 13 studies after contacting authors.
These 25 studies were reported in 99 papers. Ten studies
measured unintended pregnancy (outcome 1), and 15
studies measured pregnancy without specifying intention
(outcome 2); none measured both outcomes.
Fourteen cohort studies and 11 RCTs were included
(table 1). Pregnancy incidence was not an a priori
primary objective for any but was a secondary objective for a Rwandan HIV incidence study.32 The majority
of studies aimed to test interventions to prevent HIV
or STIs (n=11) or measure HIV incidence (n=8). Six
4

undertook substudies in which they reported pregnancy incidence.33–38 Thirteen studies included any
intervention: three involved provision of diaphragms or
female condoms,39–41 and 10 studies were biomedical or
behavioural interventions to prevent HIV/STIs (table 1).
The latter included four studies that reported providing
contraceptive counselling35 36 42 43 and one which offered
free contraception when needed.44
Most RCTs in this review required women to remain
non-pregnant for continuation.36 40 42 44–48 The majority
of studies (n=19) took place in sub-Saharan Africa,
most frequently in Kenya (n=8; table 1). There were
also studies from the Americas (Mexico and the Caribbean) and East Asia (China, Thailand and Cambodia).
All except three36 44 49 took place in urban settings. The
study areas were frequently informal housing settlements,
low-income areas or environments known for sex work
and/or drug use.
Sex work was mainly defined as exchange of sex for
money or goods (n=12) or money alone (n=4). In five
studies, sex workers were self-identified, in two studies
they were members of communities or working in areas
known for commercial sex work36 46 and in two studies no
definition was provided.48 50 Eighteen studies involved
FSWs exclusively; the remainder targeted women with
high-risk sexual practices or at high risk of HIV. These
studies either reported pregnancy incidence in the sex
work subgroup36 42 44 51 or FSWs constituted more than
Ampt FH, et al. BMJ Open 2018;8:e021779. doi:10.1136/bmjopen-2018-021779
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Kenya
(Mombasa).

Author††
Luchters et al5

Deschamps
et al74

Author††
Skoler-Karpoff
et al75

Author††

Author††
Martin et al76
McClelland
et al77
McClelland
et al78

 Chersich,34 2014

 Deschamps,33
2016

Gaffoor,42 2013

  Lara,41 2009

 McClelland,45
2008

Kenya
(Mombasa)

Dominican
Republic

South Africa
(one site of a
multisite trial)

Haiti, Puerto
Rico and
Dominican
Republic

Rwanda

Author††
Madagascar
Khan et al4
Penman-Aguilar
et al72

 Behets,40 2008

 Braunstein,32 2011 Braunstein
et al73

Madagascar

Country

 Behets,39 2005

Outcome 1: unintended pregnancy

Additional
sources

2003

2006

2004

2009

2006

2006

2005

2004

Year
started

RCT (placebocontrolled,
nested in an
open cohort
study).

Prospective
cohort (with
intervention).

RCT (phase 3,
double blind,
placebocontrolled).

Prospective
cohort.

Prospective
cohort.

Prospective
cohort.

RCT (pilot).

Prospective
cohort (with
intervention).

Design

Characteristics of included studies

Study
(first author, year)

Table 1

HIVuninfected
FSWs.

HIVuninfected
women at
high risk of
HIV exposure
(94%
reported
current sex
work).

FSWs.

310

243

HIV41
uninfected
sexuallyactive
women (3%
FSWs).

Test efficacy of monthly
HIVperiodic presumptive
uninfected
antibiotic treatment at
FSWs.
reducing incidence of vaginal
infections and promoting
vaginal Lactobacillus
colonisation.

Assess acceptability of
the female condom and
diaphragm, determinants
of use, and impact on
unprotected sex.

Test safety and efficacy of
the microbicide. Carraguard
for HIV prevention.
This substudy: describe
prevalence and associations
of forced sex.

634

386

397

Women with 192
high-risk sex
behaviours
(sex work
self-reported:
81% current,
100% ever).

FSWs who
91
use condoms
inconsistently.

Population

Assess feasibility of
HIVestablishing a high-risk
uninfected
cohort for HIV vaccine trials. FSWs.
This substudy: assess
retention, HIV and pregnancy
incidence and risk
behaviours.

Assess HIV incidence and
microbicide trial feasibility.
This substudy: investigate
links between alcohol use,
and unsafe sex and incident
HIV infection.

Measure HIV incidence
(secondary aim: measure
pregnancy incidence).

Assess acceptability and
feasibility of diaphragm
and microbicide use for STI
prevention.

Assess acceptability and
feasibility of diaphragm use.

Aim

N (FSWs) at
baseline

0% with clients
in last month
(inconsistent use
was an inclusion
criterion).

Consistent
condom use§

Any: 91%.
21% with clients
LARC or
18% with nonpermanent: 0%. paying partners.

Any (excl.
0% in last
condoms): 24%. 2 weeks
(inconsistent use
was an inclusion
criterion).

Any: 47%
LARC or
permanent:
<1%.

Current
contraceptive
use‡ (%)

32

58.8%
aged
20–29
years

§§

24‡‡

N/A.

0.5% in last
6 months.

Any (excl.
condoms):
35.5%.
LARC: 3.6%.
Permanent:
2.9%.

Median 100%
coverage of
sex acts in past
week.‡‡

Any (excl.
66% in last
condoms):
month.
22.2%.
Permanent: 0%.

§§

Permanent:
10.0%
(excluded from
pregnancy
analysis).
Others not
reported.

Mean 25.1 Any (incl.
21.3% in last
consistent
3 months.
condom use):
57.1%.
LARC: 3.0%.
Permanent: 0%.

24

29

28

Age
(median)†

One partner.
One sex act.‡‡

N/A.

§§

447 partners in
last 6 months‡‡.

N/A.

90 partners in past
3 months.
10 clients per
week.
40 vaginal sex
acts in last month.

Six casual
partners.
10 sex acts.

Five partners.
Six sex acts.

Vaginitis/Pelvic
inflammatory
disease (PID):
8%.
TP (RPR): 27%.

HIV/STI
prevalence

N/A.

CT: 5%.
GN: 12%.
TV: 17%.
TP
(RPR+TPHA pos):
7%.
HSV2: 54%.

N/A.

Ever had abortion:
70%.

N/A.

Continued

GN: 0.3%.
TV: 1%.
Cervicitis
(microscopy):
0.6%.
HSV2: 74%.
BV: 34.5%.

HIV: 1%.
CT: 13%.
GN: 2%.
TP (VDRL): 8%.

§§

Forced sex by client N/A.
in last 6 months:
37.1%.
Heavy drinker:
38.8%.
Drug use: 14.0%.

Hazardous or
harmful drinking:
26.8%.
Ever had abortion:
21%.

Forced sex ever:
19%.
Alcohol before sex:
52%.

Ever violence from
N/A.
casual partner for
suggesting condom:
21%.
Ever received
more money for no
condom: 38%.

N/A.

Gender-based
Number of
violence (GBV)/
sex partners/
alcohol/other risk
frequency of sex¶ factor
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Author††
Macqueen
et al66

Author††
Odutola et al79

 Peterson,46 2007

 Watson-Jones,44
2008

Tanzania

Ghana,
Cameroon
and Nigeria

Country

Rerks-Ngarm
et al83

Yadav et al84
Fonck et al85

 Kaewkungwal,36
2013

 Kaul,47 2004

Kenya
(Nairobi)

Thailand (two
provinces)

Feldblum et al57 Madagascar
Hoke et al82

 Feldblum,35 2007

Cambodia

Mexico

Author††
Duff et al55
Couture et al81

Author††
Syvertsen
et al80

 Page,38 2013

 Bazzi,54 2015

Outcome 2: pregnancy (intention undefined)

Additional
sources

Continued

Study
(first author, year)

Table 1

1998

2003

2001

2009

2010

2004

2004

Year
started

RCT (double
blind placebo
controlled).

RCT (multisite
double blind
placebo
controlled).

RCT.

Prospective
cohort.

Prospective
cohort.

RCT (double
blind, placebo
controlled).

RCT (phase
2, double
blind, placebo
controlled).

Design

Assess impact of monthly
PPT on HIV and STI
incidence.

Assess the efficacy of two
vaccines to prevent HIV.
This substudy: determine the
qualities and outcomes of
women's participation.

Assess impact of two
condom promotion
interventions.
This substudy: estimate
pregnancy incidence rate
and predictive factors.

Estimate HIV and STI
prevalence, incidence and
associated factors.
This substudy: describe
contraceptive utilisation
and correlates of incident
pregnancy.

Identify time varying risk
factors for STI acquisition
within FSWs’ intimate
partnerships.

Determine whether HSV2
suppressive therapy reduces
the risk of HIV acquisition
and genital shedding of HIV.

Investigate safety and
preliminary effectiveness of
tenofovir disoproxil fumarate
in preventing HIV infection.

Aim

212

499

HIVuninfected
FSWs.

HIVuninfected
women (5%
FSWs).

FSWs.

430

318

935

Young women 220
who practice
SW and/or
have multiple
partners
(all those
recruited had
practiced
SW).

FSWs with
drug use
history
and their
steady male
partners.

Female
workers at
food and
recreational
facilities at
risk of HIV
(38% FSWs).

936
HIVuninfected
women
who work in
hotels, bars,
markets in
high HIV
transmission
areas (areas
known for sex
work).

Population

N (FSWs) at
baseline

Any hormonal
(not LARC):
10.8%.
LARC: <1.0%.

Any (excl.
condoms):
53.3%.
LARC: 12.3%.
Permanent:
25.5%.

§§

Any (excl.
condoms):
7.22%.
LARC: <2%.
Permanent:
<2%.

Current
contraceptive
use‡ (%)

28.6‡‡

N/A

Any hormonal
(not LARCs):
39.1%.

N/A.

Mean 28.3 Any highly
effective (excl.
condoms):
16.3%.

60.3%
aged
25–29
years

33

§§

Mean
23.6‡‡

Age
(median)†

17.2% with
casual partner.‡‡

§§

No unprotected
sex with any
partners: 13.2%.

N/A.

Often or always:
56%.

§§

N/A.

Consistent
condom use§

15.4 partners.‡‡

N/A.

Mean 5–6
partners.

Four partners in
last month.

N/A.

§§

Mean 21 partners
in 30 days.
Mean 12 coital
acts per week.

HIV: 2.6%.
CT: 5.9%.
GN: 1.2%.
TP (active): 1.4%.
Any STI: 8%.

§§

Any STI in last
6 months (selfreported): 41.2%.

HIV/STI
prevalence

Daily alcohol:
47.6%.
Ever intravenous
drug use: 4.1%.

§§

N/A.

Continued

CT: 9.9%.
GN: 10.3%.
TV: 12.2%.
TP: 4.4%.
HSV2: 73.9%.
BV: 51.1%.

N/A.

CT: 14.6%.
GN: 21.7%.
TV: 11.7%.
Any STI: 36.1%.
‡‡

In last year: physical HIV: 16.2%.
or sexual violence
by client: 26.0%.
Intimate partner:
20.1%.
In last 3 months:
stimulant drug use:
27.0%.
Abortion: 11.3%.

In last year:
physical assault by
partner: 41%.
Sexual coercion in
relationship: 9%.
In last 6 months:
hazardous drinking:
23%.
Intravenous drug
use: 62%.

§§

N/A.

Gender-based
Number of
violence (GBV)/
sex partners/
alcohol/other risk
frequency of sex¶ factor
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Author††
Vera et al88
Gaines et al89

Author††
Vandebosch
et al90
Ramjee
et al91

 Strathdee,43 2013

 Van Damme,48
2002

2008

2009

2008

2005

1993

2009

Year
started

Benin, Cote
1996
d'Ivoire, South
Africa and
Thailand

Mexico

Kenya,
Tanzania and
Uganda

Kenya
(Nairobi, Kilifi)

Author††
Rono et al87

Author††

 Price,49 2012

Kenya
(Mombasa)

 Robb,51 2016

Author††
Martin et al76
McClelland
et al86

 McClelland,37
2011

China

Kenya
(Nairobi)

Author††

 Liu,53 2015

Country

 Priddy,56 2011

Additional
sources

Continued

Study
(first author, year)

Table 1

RCT (multisite
triple blind
placebocontrolled;
open cohort
design).

RCT (four-arm
factorial).

Prospective
cohort.

Prospective
cohort.

Prospective
cohort.

Open cohort.

Cluster RCT.

Design

Determine effectiveness of
nonoxynol-9 microbicide in
prevention of HIV-1.

Determine effectiveness of
two behavioural interventions
to reduce sexual and
injecting risk.

Describe the trajectory of
acute HIV infection.

898

750

HIVuninfected
FSWs.

HIVuninfected
FSWs who
inject drugs.

HIVuninfected
women and
men at high
risk for HIV
(64% FSWs).

892

584

1463

200

HIV515
uninfected
women and
men at risk of
HIV (75% of
women were
FSWs).

HIV-infected
FSWs.

FSWs.

Population

Assess HIV risk behaviour
HIVand incidence, STI
uninfected
prevalence, vaginal practices FSWs.
and retention.

Describe populations at
risk of HIV, including HIV
incidence, in preparation for
HIV trials.

Assess HIV-1 incidence
and relationships between
hormonal contraception,
STIs and HIV.
This substudy: examine
relationship between risk
behaviour and biologic
outcomes (STI, pregnancy,
seminal fluid deposition)
among HIV-positive FSWs.

Assess the impact of a
preventive intervention for
FSWs on condom use with
clients and partners.

Aim

N (FSWs) at
baseline

26

33

N/A

Mean 28

§§

31

Mean
27.8‡‡

Age
(median)†

N/A.

55% in past
week.

43.6% in past
month.

Consistent
condom use§

N/A.

One partner.
Two sex acts.

Mean 8.3
clients.‡‡

N/A.

Any (excl.
condoms):
39.3%.
LARC: 25.3%.
Permanent:
17.8%.

Any hormonal
(incl. implant):
36.5%.
IUD: 0.5%.
Permanent:
0.5%.

30 clients per
month.
51 paid sex acts
per month.

N/A.

N/A (only reported Three partners
use of condom
per day.
in ≥50% of sex
acts).

14.9% with
regular clients.
11.7% with
casual clients.

32.6% with
clients.
20.3% with nonpaying partners.

N/A.

N/A.

Abortion in last
3 months: 0.43%.

Sexual/physical
violence related to
Sex work (SW) in
last month: 19.5%.
Sometimes/always
paid more for no
condom: 29.0%.
Sometimes/always
has sex while
intoxicated: 31.5%.

§§

N/A.

N/A.

Gender-based
Number of
violence (GBV)/
sex partners/
alcohol/other risk
frequency of sex¶ factor

Any non-barrier N/A (only reported Mean per day:
method: 52.0%. sometimes/
2.4 regular clients.
LARC: 3.0%.
always use).
1.9 casual clients.
Permanent:
1.0%.

N/A.

Any (excl.
condoms):
43.0%.
LARC: 2.34%.
Permanent:
2.67%.

LARC: 29.9%.

Current
contraceptive
use‡ (%)

Continued

CT: 4.4%.
GN: 5.1%.
TV: 3.5%.
TP: 11.2%.

CT: 12.0%.
GN: 2.2%.
TV: 33.6%.
TP (active): 8.4%.

N/A.

CT: 5.5%.
GN: 6.0%.
TV: 9.0%.
TP: 2.5%.
HSV2 (antibody):
72.0%.
BV: 38.0%.

Any nonulcerative STI:
9.1%.
Genital ulcers:
1.5%.
TP: 0.6%.
Any STI: 10.6%.

N/A.

CT: 14.0%.
GN: 3.3%.
TP: 1.3%.
Any STI: 16.9%.

HIV/STI
prevalence
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Author††
Naicker
et al92

 van
Loggerenberg,52
2008

Author††

Kenya
(Nairobi)

Uganda
(urban slum).

South Africa
(Durban)

Country

2009

2008

2004

Year
started

Prospective
cohort.

Prospective
cohort.

Prospective
cohort.

Design
HIVuninfected
women who
practice SW
(79%) and/or
have multiple
partners.

Population

Compare the duration of high FSWs.
risk HPV infection among
FSWs by exposure to STIs,
using a highly sensitive
biomarker assay.

Understand dynamics of HIV FSWs.
and STI infections among
FSWs.
This substudy: investigate
patterns of clearance and
recurrence of untreated
Mycoplasma genitalium
infection.

Understand HIV-1 subtype
C acquisition, pathogenesis
and disease progression.
This substudy: describe
cohort characteristics
and HIV-incidence rates,
and report challenges in
establishing and maintaining
the cohort.

Aim

350

1027

193

N (FSWs) at
baseline

28

Mean 26

LARC: 15.5%.
Permanent:
2.1%.

N/A.

Mean 34.3 N/A.

Age
(median)†

Current
contraceptive
use‡ (%)

Most of the time/
always:
73.8% with
clients.
24.6% with nonpaying partners.

59.8% in last
month.

53.9% with
casual partners.
20.4% with
steady partners.

Consistent
condom use§

N/A.

10 partners per
week.

N/A.

At least daily sex
Problem drinking:
for money: 50.5%. 55.7%.

Two partners per
week.

Gender-based
Number of
violence (GBV)/
sex partners/
alcohol/other risk
frequency of sex¶ factor

HIV: 24.0%.
CT: 3.8%.
GN: 2.3%.
TV: 7.3%.
MG: 12.8%.

MG: 14%.

Any STI (CT,
GN, TV, MG, TP,
HSV2): 31.3%.

HIV/STI
prevalence

†Median unless specified.
‡Any=modern contraceptive method including condoms, unless specified; LARC=long-acting reversible contraception (implants or IUDs); Permanent=any method of permanent contraception, for example, tubal ligation or hysterectomy.
§Always uses condoms (unless specified).
¶Median number per week unless specified. Sex partners may be paying, non-paying, regular or casual, unless specified.
††‘Author’ indicates additional data were obtained from the author. Other references listed here reported on the same study and were used for data extraction.
‡‡Reported results segregated by sub-group; data presented here are overall estimates.
§§Not disaggregated by sex work status.
BV, bacterial vaginosis; CT, Chlamydia trachomatis; FSW, female sex worker; HSV2, herpes simplex virus type 2; MG, Mycoplasma genitalium; N/A, not measured or reported, data not available from author; NG, Neisseria gonorrhoeae; RCT, randomised
controlled trial; STI, sexually transmitted infection; TP, Treponema pallidum (syphilis); TV, Trichomonas vaginalis.

 Vielot,50 2015

 Vandepitte,93 2013 Author††
Vandepitte
et al94

Additional
sources

Continued

Study
(first author, year)
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two-thirds of the sample.32 40 49 52 Fourteen studies were
restricted to women without HIV at baseline, and one
study to women living with HIV.37
Most studies (n=15) were conducted for 1–2 years,
although they ranged from a 1 month pilot RCT40 to a
15-year open cohort study.37 The studies reporting pregnancy (intention undefined) tended to be of longer duration than those reporting unintended pregnancy (median
duration 24 and 12 months, respectively; table 2).
Baseline population characteristics
Most study populations had a median of 5–8 years of
education, and the majority of women were supporting
at least one financial dependent (data not shown).
Median duration in sex work was 3–5 years for most
study populations, with one notable exception of 14
years in a study in Mexico.43 Concurrent non-paying
sex partners were common, reported by 30%–100% of
women in 12 studies.
Permanent and long-acting reversible contraceptive use
was around 1% in most studies in Africa, with only one
study in Kenya reporting significantly higher coverage
(17.5%).50 By contrast, coverage of these methods was
greater than 30% in China53 and Mexico.43 54 Consistent
condom use was measured using diverse metrics but was
generally low and very low with non-paying partners. Most
studies reported frequent sex with multiple partners,
and few reported a median of less than five partners per
week.37 45 52 55 High rates of gender-based violence were
noted in all studies in which this was measured, as well
as physical or financial pressure not to use condoms.40 56
While the factors described generally contributed to
high baseline pregnancy risk, several studies included
FSW with notably lower risk profiles. For example, two
studies were part of a large Kenyan open cohort, in which
participants had few partners and sex acts per work,
and older median age and lower STI prevalence than
the other studies.37 45 In addition, a number of studies
provided insufficient information to assess population
risk for pregnancy.
HIV prevalence was reported in four studies and
varied from 24 % in Kenya 50 to less than 3 % in Mexico
54
and Dominican Republic. 41 STIs other than HIV
were prevalent, with one study reporting up to 36% of
the study population having at least one STI on biological testing.35 57
Methodology and quality assessment
Quality scores, as percentages of the available total, are
presented in table 2. The median quality score was 40%
(IQR=36%–50%). Four studies scored 60% or greater;
three of these measured unintended pregnancy32–34 and
one measured pregnancy (undefined).53 Most studies
scored poorly in the external validity and selection bias
categories.
Measurement bias was an issue for some studies. Pregnancy was tested regularly in all but one44 of the unintended pregnancy studies; in contrast, five pregnancy
Ampt FH, et al. BMJ Open 2018;8:e021779. doi:10.1136/bmjopen-2018-021779

(undefined) studies only measured it if suspected
by the clinician or participant. Five of the pregnancy
(undefined) studies measured pregnancy using self-report rather than a biological test.
Incidence of pregnancy
Incidence rate was reported by 14 studies and calculated
for the remainder based on the available data, with the
number of women who became pregnant as the numerator and person-years as the denominator. Women were
censored at the time they became pregnant. The one
exception was Deschamps et al,33 who counted multiple
pregnancies and subtracted pregnancy time from total
person-time.
Unintended pregnancy incidence rate (outcome 1)
varied widely between studies, ranging from 7.2 to 59.6
pregnancies per 100 person-years (table 2; figure 2).
The median rate of the 10 studies was 26.8, and seven
reported a rate of greater than 20 per 100 person-years.
Incidence rate of pregnancy (intention undefined –
outcome 2) also varied widely, but rates were lower overall
than unintended pregnancy, ranging from 2.0 to 23.4
per 100 person-years (table 2). The median rate of the 15
studies was 13.5, and only two reported a rate of greater
than 20 per 100 person-years.
Meta-analyses
Random effects meta-analyses were performed for the two
primary outcomes. Heterogeneity was high, with I2 statistic
over 95% for both outcomes.
Incidence of unintended pregnancy
Explored covariates that may explain the high heterogeneity of unintended pregnancy incidence showed that
geographical region did not explain this, whereas presence/absence of an intervention seemed important. The
three cohort studies that did not involve an intervention
had very low heterogeneity (I2=0%), and the pooled estimate for these studies was 27.1 unintended pregnancies
per 100 person-years (95% CI 24.4 to 29.8; figure 3). These
three studies scored at least 60% on quality assessment
(table 2).
Assessment of potential methodological explanations
showed that study design (RCT vs cohort) and study duration seemed important sources of heterogeneity, while
pregnancy measurement method did not explain the high
heterogeneity. The cohort studies were more homogenous
than the RCTs (I2=63.9% and 96.8% respectively), and
had higher pooled incidence of unintended pregnancy
(figure 4). The three studies of less than 1 year duration
were more homogenous (I2=59.1%) and had higher incidence (44.5 per 100 person-years) than longer studies
(figure 5).
Quality was not found to be a source of heterogeneity,
as no relationship was demonstrated between study quality
score and unintended pregnancy incidence rate (Pearson
correlation coefficient 0.01; scatter plot not shown).
9

BMJ Open: first published as 10.1136/bmjopen-2018-021779 on 17 September 2018. Downloaded from http://bmjopen.bmj.com/ on November 5, 2020 by guest. Protected by copyright.

Open access

Table 2 Results of included studies reporting unintended pregnancy and pregnancy (intention undefined) in ascending order
of incidence

Study

Incidence
rate (per 100
person-years)

95% CI

Personyears of
exposure

Duration
(months)

Measurement Frequency of
of pregnancy measurement

Quality
(%)
40

Unintended pregnancy
7.2
 McClelland
 
et al77

4.5 to 10.9

305.4

12

Urine test

Monthly

 Watson-Jones
 
et al44

11.8

9.7 to 14.5

796

30

Urine test

Quarterly on suspicion 53
only

 Gaffoor
 
et al42

13.4

6.1 to 25.4

67.2

24

Urine test

Quarterly

20

 Behets
 
et al40

20.7

4.3 to 60.5

14.5

1

Urine test

Weekly

27

 Braunstein
 
et al32

26.3

21.9 to 30.7

528.5

24

Serum test

6 monthly for
60
1 year+1 measurement
in second year

 Deschamps
 
et al33

27.3

23.3 to 31.7

615.6

18

Test
(unspecified)

6 monthly

67

 Chersich
 
et al34

28.0

22.6 to 34.3

335.8

12

Urine test

Quarterly

60

 Peterson
 
et al46

51.7

44.9 to 59.3

400

12

Urine test

Monthly

40

 Behets
 
et al39

53.0

21.0 to 110.0

13.2

2

Urine test

Monthly

40

 Lara
 
et al41

59.6

41.7 to 82.5

60.4

4

Urine test

Monthly

40

Pregnancy (intention undefined)
 Robb
 
et al51

2.0

1.4 to 2.9

1619.6

24

Self-report

Quarterly on suspicion 21
only

 McClelland
 
et al37

2.7

2.1 to 3.5

2259.3

15-year
open
cohort *

Urine test

Monthly on suspicion
only

21

 Bazzi
 
et al54

3.3

1.4 to 5.2

359.6

24

Self-report

6 monthly

43

 Strathdee
 
et al43

5.9

4.1 to 8.4

540.1

12

Self-report

4 monthly

36

 van
Loggerenberg
 
et al52

8.5

5.6 to 11.5

376.5

24

Urine test

Monthly on suspicion
only

36

 Van Damme
 
et al48

8.6

6.7 to 10.8

837.5

≤24*

Urine test

Quarterly

29

 Vielot
 
et al50

12.6

9.7 to 16.1

500.8

24

Urine test

Quarterly on suspicion 50
only

 Kaul
 
et al47

13.5

11.3 to 16.1

968.0

≤48*

N/A

N/A

21

 Priddy
 
et al56

14.2

7.6 to 24.3

91.5

6

Urine test

Quarterly

36

 Price
 
et al49

14.5

12.0 to 17.5

784.0

48

Urine test

Quarterly

43

 Liu
 
et al53
 Kaewkungwal
 
et al36

15.2

10.4 to 21.5

210.3

6

Self-report

Quarterly

71

15.8

13.0 to 19.0

721.0†

42

Urine test

N/A

43
Continued
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Table 2 Continued
Incidence
rate (per 100
person-years)

 Vandepitte
 
et al93
 Page et al38
 Feldblum
 
et al35

Study

95% CI

Personyears of
exposure

Duration
(months)

Measurement Frequency of
of pregnancy measurement

Quality
(%)

18.3

16.2 to 20.6

1467.0

≥24*

Urine test

N/A

50

22.0
23.4

16.3 to 30.1
20.6 to 26.5

186.4
1067.5

12
18

Self-report
Urine test

Quarterly
6 monthly on
suspicion only

50
43

*Duration varied for different participants.
†Person-time estimated by: (n_FSWs * yrs * retention) − (n_preg * yrs/2); where: n_FSWs, number of FSWs enrolled; yrs, study duration in
years; retention, retention rate; n_p reg, number of women who became pregnant. We could not use the approach advocated by Vandenbrou
c ke et al 95 as average follow-up time among FSWs was not known.
FSWs, female sex workers; N/A, not measured or reported, data not available from author.

Incidence of pregnancy (intention undefined)
Subgroup analyses showed that study duration and
geographic region were sources of heterogeneity for rates
of pregnancy where intention was not known. Pregnancy
measurement method and study design characteristics
did not account for any heterogeneity for this outcome.
There were only two studies of less than 1-year duration53 56 (I2 0%). As with the unintended pregnancy
outcome, these studies had a higher pooled incidence
than studies of more than 1 year duration (14.9 vs 11.4
per 100 person-years).
A subanalysis of geographic region showed that studies
from Asia and the Americas (both in Mexico) were more
homogenous (I2=29.8% and 68.1%, respectively) than
those from sub-Saharan Africa (I2=98.3%). The pooled
incidence of pregnancy was higher in Asia (16.8 per 100

Figure 2

person-years) and lower in Mexico (4.8 per 100 personyears; figure 6).
A scatter plot demonstrated a weak positive relationship between quality score and incidence rate (plot not
shown; Pearson correlation coefficient 0.55).
Secondary outcomes
Three studies assessed pregnancy outcomes for FSWs
(table 3). In two of the studies, outcomes were unknown
for about 25% of pregnancies (in the Caribbean33 and
Madagascar,35) resulting in underestimates of birth and
abortion incidence. Abortion accounted for less than
20% of pregnancies with known outcomes. In contrast, in
the third study, a multicountry study,48 62 abortions were
recorded as adverse events (author correspondence),
compared with only 10 reported as withdrawing from the

Incidence rates (per 100 person-years) for studies reporting unintended pregnancy.
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Figure 3 Forest plot showing subgroup analysis of unintended pregnancy incidence rates (per 100 person-years) by
intervention versus no intervention.

study due to pregnancy, suggesting that over 85% of the
total women who became pregnant reported an abortion.
Four studies developed multivariate regression models
to determine the predictors of pregnancy35 37 or unintended pregnancy.5 33 Common findings were that

younger age was associated with higher pregnancy incidence5 33 35 and that highly effective contraceptive use35
and consistent condom use35 37 were protective; however,
one study in Kenya found that using condoms at the
exclusion of other methods was a risk factor.5 Having a

Figure 4 Forest plot showing subgroup analysis of unintended pregnancy incidence rates (per 100 person-years) by RCT
versus cohort study design. RCT, randomised controlled study.

12

Ampt FH, et al. BMJ Open 2018;8:e021779. doi:10.1136/bmjopen-2018-021779

BMJ Open: first published as 10.1136/bmjopen-2018-021779 on 17 September 2018. Downloaded from http://bmjopen.bmj.com/ on November 5, 2020 by guest. Protected by copyright.

Open access

Figure 5 Forest plot showing subgroup analysis of unintended pregnancy incidence rates (per 100 person-years) by study
duration (cut-off 1 year).

main or emotional partner increased the odds of unintended pregnancy5 33 but not of pregnancy (intention
undefined).35 37 Deschamps et al noted some additional

associations, including recreational drug use and male
partners having other sex partners being protective
against pregnancy. Only one study assessed reproductive

Figure 6 Forest plot showing subgroup analysis of pregnancy (intention undefined) incidence rates (per 100 person-years) by
geographic region.
Ampt FH, et al. BMJ Open 2018;8:e021779. doi:10.1136/bmjopen-2018-021779
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Table 3 Incidence of abortion and birth

Study

Site

Deschamps et al33

Haiti, Puerto
Unintended
Rico and Dominican pregnancy
Republic
Madagascar
Pregnancy
(intention
undefined)
Benin, Cote d’Ivoire, Pregnancy
South Africa and
(intention
Thailand
undefined)

Feldblum et al35

Van Damme et al48

Outcome

history and income,5 and none considered HIV status as
potential predictors or confounders.
Discussion
This review found that of the many studies examining
FSWs’ sexual and reproductive health in LMICs, very few
have measured pregnancy and even fewer have assessed
pregnancy intention. While incidence varies widely
between the included studies, it is sufficiently high in
most low-income and middle-income contexts to constitute a significant health and social issue for FSWs.
Study design impacted on unintended pregnancy rates,
with a lower rate seen in RCTs (20.8 per 100 person-years)
than cohort studies (29.6 per 100 person-years). Most
of the RCTs in this review required women to remain
non-pregnant for continuation36 40 42 44–48 and although
only six RCTs specifically mentioned providing contraceptive counselling or methods, others may have offered
a larger package of services that was not reported.
To better understand the influence of services provided
by studies, we compared studies that provided any intervention with those that did not and found that the three
studies in the latter category had very low heterogeneity
and high pooled unintended pregnancy incidence (27
per 100 person-years). As non-intervention cohort studies
with quality scores of at least 60%, these were arguably the
best designed to answer the review question.
The included studies may have underestimated population incidence of pregnancy, for several reasons. First,
studies that only tested for pregnancy on suspicion could
have missed early pregnancies or failed to ascertain the
need to test. Second, pregnancies occurring between
study visits and ending in spontaneous or induced abortion may have been missed. Third, social desirability
bias is likely to influence self-reporting of pregnancy in
studies using that measure. Fourth, participants may have
joined some studies in order to access services, potentially receiving superior family planning services than
would otherwise be accessible.58 Finally, there may be
selective loss to follow-up among women who become
pregnant, particularly in drug trials requiring women
14

Incidence of Incidence of
pregnancy
birth

Abortion (as
proportion of
Incidence pregnancies with
of abortion known outcome)

27.3

15.1

3.1

16%

23.4

11.9

3.0

17%

8.6

Not measured 7.4

>85%

to remain non-pregnant for continuation.36 40 42 44–48 It is
possible that these factors were more prominent in the
studies measuring pregnancy without defining intention,
contributing to the surprising finding that this outcome
had generally lower incidence rates than unintended
pregnancy.
Some ‘unintended’ pregnancies may in fact have been
intended, because women may have been unsure about
their intention or it changed over time.27 Only one study
assessed intention repeatedly,34 and none used a validated
instrument designed to measure this complex latent
construct.59 Some participants may have wanted a pregnancy but felt pressure to say otherwise, depending on
the social environment, external and internal stigma and
the study design, for example, if they wanted to access
HIV prevention and other services through the study
but inclusion was restricted to those not wanting to get
pregnant.
Conversely, it is likely that most women in the undefined intention category (outcome 2) who became pregnant may not have intended to do so. During recruitment
for a pregnancy prevention intervention trial with FSWs
in Kenya,6 less than 1% of those interested in taking part
were planning to get pregnant in the next year (unpublished data). Similarly, in a cohort study included in
this review, only 4% of participants expressed an intention to get pregnant at some point during the 12-month
follow-up.5 34 A study in South Africa found a higher
proportion (10%) wishing to conceive, but this is still
a small minority of FSWs. While immediate pregnancy
intentions may be low, however, future fertility preferences may be comparable with other women,60 and
several authors have highlighted the need for appropriate
services that promote safe conception and address FSWs’
need for different forms of protection with different partners.22–24 60
Quality scores were low, but it is important to note
that we were assessing how well the studies answered our
research question, rather than their own stated objectives.
However, there was a notable absence of well-described
sampling and recruitment techniques, suggesting that
Ampt FH, et al. BMJ Open 2018;8:e021779. doi:10.1136/bmjopen-2018-021779
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study populations may have been poorly representative
of local FSW populations. This may have underestimated
pregnancy incidence, as more marginalised members
of the population, who are at greater sexual risk, are
harder to reach and recruit by convenience or snowball
methods. Indeed, the only study to use a random sampling
approach found moderately high incidence of pregnancy
(intention undefined; 15 per 100 person-years), despite
30% IUD coverage in this population.53 Furthermore,
inclusion criteria limiting more than half of the studies
to HIV negative women contributed to selection bias,
particularly in sub-Saharan African studies, where HIV
prevalence among FSWs is estimated at 37%.61 This may
partly explain the observation that pregnancy incidence
in sub-Saharan Africa was lower than Asia, despite the
fact that total population fertility rates are lower in Asia.
Higher quality scores seen in the Asian studies may also
account for this discrepancy.
Quantitative analysis identified study duration as a clear
contributor to heterogeneity in both outcomes. Incidence
was lower in shorter studies and decreased over time
within studies that reported incidence at multiple time
points.32 35 This is due in part to the analytical approach,
taken by all but one study,33 of censoring women’s persontime when they first become pregnant. As study subjects
at highest risk fall pregnant early, they are censored early
and cannot contribute additional pregnancies to the
numerator. The remaining lower risk women are less
likely to experience the outcome. The same phenomenon
has been observed in closed cohorts with the outcome of
HIV incidence.62 In addition, sexual risk behaviours often
reduce over time in longitudinal studies, because of social
desirability bias or health education from study participation,33 36 or attrition bias,63 which may have been a factor
for 12 studies in this review with low or unreported retention rates among FSWs.
While measurement bias did not emerge as a significant source of heterogeneity, there was ambiguity in the
reporting of pregnancy measurement, and it was often
dependent on authors’ recollections. There was a weak
positive association between study quality and incidence
rates in the pregnancy (intention undefined) group. The
lack of a clear relationship may be because quality issues
can result in either an underestimate or overestimate of
incidence.
Limitations
This review had a number of limitations. Foremost was
the inclusion of studies in which (unintended) pregnancy incidence was not an a priori objective, which was
the case for all but one. This likely resulted in methodological issues affecting participant selection and pregnancy measurement.
We also adopted a broad approach to other inclusion
criteria. Several studies conducted in the late 1990s and
early 2000s were included, which may be problematic as
family planning coverage has grown and fertility rates
declined since that time. The heavy reliance on authors
Ampt FH, et al. BMJ Open 2018;8:e021779. doi:10.1136/bmjopen-2018-021779

to provide unreported data was a limitation and may
have introduced bias, and older data often could not
be accessed.
We used a broad definition of sex work, which may
have increased the heterogeneity of the outcomes.
However, this definition reflects the reality that there
are many reasons for women to sell sex, which depend
on local laws, culture and economies, and to arbitrarily limit to full-time sex workers, for example, may
exclude studies of ‘hidden’ FSWs who are often especially vulnerable. 64 65
Our analysis was limited by high heterogeneity,
which prevented us from pooling overall rates or
performing meta-regression to tease out the influence
of different variables. Heterogeneity was not fully
explained by explorative subanalyses and may in part
be due to the low number of studies, low quality and
incomplete data on risk factors. It should be noted
that interpretation of these descriptive heterogeneity
statistics require a certain level of caution, specifically where the number of cases is small. Variations
in baseline population risk probably contributed
significantly to heterogeneity, but these could not be
quantified due to the incomplete and/or inconsistent
measurement of risk factors between studies. Cultural,
legal and economic contexts, such as cultural norms
around motherhood and abortion law, also vary
considerably between the different settings in which
the studies took place, and influence fertility preferences, expression of pregnancy intention and access
to prevention methods and abortion. These contextual factors could not be accounted for in our analysis.
Another limitation was that we were unable to
directly compare rates of pregnancy between FSWs
and other populations. Very high pregnancy incidence has been observed in HIV studies among
women not categorised as sex workers66 67; however,
these women were at high risk for HIV for other
reasons (eg, multiple partners). Among the general
population, unintended pregnancy incidence is estimated at 5.4 per 100 person-years in the developing
world, and eight in Africa,68 substantially lower than
the rates among FSWs presented here. Of the three
studies in this review, which reported incidence for a
broader study population as well as an FSW subgroup,
two reported higher incidence 36 42 and one reported
approximately equal incidence44 in the FSW subgroup
compared with the whole study population.
Conclusion
Ultimately, this review demonstrates a concerning
lack of research on an issue which is a priority for
many FSWs in low-resource settings. This is surprising
as we found many studies on HIV incidence and
prevention in this population, for which unintended
pregnancy is both relevant to the primary outcome
and may indicate overall sexual risk. There has been
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a modest increase in family planning availability for
women in many countries since the early 2000s69 70;
however, this has not been accompanied by research
on whether these additional services have reached
FSW populations or impacted on pregnancy rates.
Access to family planning, particularly long-acting
reversible contraceptives, may be improved by better
targeting of FSWs through mobile outreach71 and
integration with existing FSW-specific HIV prevention
services, and by careful training of health workers
and community workers in contraceptive counselling
and follow-up. 71 Also, it is important that concerted
efforts are made to link FSWs who become pregnant
with maternal health services, including services for
antiretroviral treatment and preventing HIV transmission to infants.
This review found that studies measuring pregnancy
incidence among FSWs were of low overall methodological quality and had highly varied results but that unintended pregnancy incidence was high overall and, based
on available data, higher than the general population.
There is an urgent need for quality research on unintended pregnancy incidence, the effectiveness of interventions to reduce it and the best models of reproductive
health service provision for this large and stigmatised
population.
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